ATMS 1.29 Artemis Therapeutics Inc.
| Range: | 0.1121-4.5 | Vol Avg: | 1534 | Last Div: | 0 | Changes: | -1.39 |
| Beta: | 0 | Cap: | 0.06B | Currency: | USD | Exchange: | PNK |
| Sector: | Financial Services | IPO: | Tue Feb 17 1998 | Empoloyees: | 4 | ||
| CUSIP: | 04302Q109 | CIK: | 0001062128 | ISIN: | Country: | US | |
| CEO: | Mr. Shimon Citron | Website: | https://www.artemis-therapeutics.com | ||||
Artemis Therapeutics Inc. does not have significant operations. Previously, it was involved in the development of agents for the prevention and treatment of severe and life-threatening infectious diseases. The company is based in New York, New York. Artemis Therapeutics Inc. is a subsidiary of Tonak Ltd.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow